FUTURE LEADERS IN ATHEROSCLEROSIS RESEARCH AND EDUCATION (FLARE)

MINERVA MILL INNOVATION CENTRE, STATION ROAD, ALCESTER  B49 5ET
  • Dissolved
  • PRI/LBG/NSC (Private, Limited by guarantee, no share capital, use of 'Limited' exemption)
  • Company No. 09987457
  • Last Updated: 27 Jun 2021

Company Profile

FUTURE LEADERS IN ATHEROSCLEROSIS RESEARCH AND EDUCATION (FLARE) was incorporated on Thursday, February 4, 2016 as a PRI/LBG/NSC (Private, Limited by guarantee, no share capital, use of 'Limited' exemption) with registered address in ALCESTER. FUTURE LEADERS IN ATHEROSCLEROSIS RESEARCH AND EDUCATION (FLARE) has the status: Dissolved and it's listed in the following category: Other education not elsewhere classified. This PRI/LBG/NSC (Private, Limited by guarantee, no share capital, use of 'Limited' exemption) has been operating for 5 years 3 months and 21 days.

Name FUTURE LEADERS IN ATHEROSCLEROSIS RESEARCH AND EDUCATION (FLARE)
Company number 09987457
Company type PRI/LBG/NSC (Private, Limited by guarantee, no share capital, use of 'Limited' exemption)
Incorporation date 04 Feb 2016
Status Dissolved
Industry (SIC 2007)

Address

Registered Address MINERVA MILL INNOVATION CENTRE
STATION ROAD
ALCESTER
B49 5ET
Country Of Origin UNITED KINGDOM

Map based on PostCode

Ownership Information

Individuals and organizations with significant control over the business either by owning at least 25% shares or by virtue of significant influence over the business.

Name Nature of Control
Mr Michael Whittingham Gibbs Nationality: British Dates: Friday, February 3, 2017 - present
significant influence or control

Accounts and Confirmation

Type of accounts MICRO
End of financial Year 31 March
Next annual accounts due Not available
Latest accounts 31 March 2020
Next confirmation statement due Not available
Last confirmation statement dated 03 February 2021

Mortgages

No mortgages have been registered against FUTURE LEADERS IN ATHEROSCLEROSIS RESEARCH AND EDUCATION (FLARE).

Previous Names

Name Change Date
FUTURE LEADERS IN ATHEROSCLEROSIS RESEARCH AND EDUCATION (FLARE) 04 Feb 2016